Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial

Avezum, A; Lopes, RD; Schulte, PJ; Lanas F.; Gersh, BJ; Hanna M.; Pais, P; Erol, C; Díaz R; Bahit, MC; Bartunek, J; De Caterina R; Goto, S; Ruzyllo, W; Zhu J.; et. al.

Keywords: stroke, hemorrhage, atrial fibrillation, heart diseases, oral anticoagulant, apixaban, valvular heart disease

Más información

Título según WOS: Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
Título según SCOPUS: Apixaban in comparison with warfarin in patients with atrial fibrillation and valvular heart disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (Aristotle) trial
Título de la Revista: Circulation
Volumen: 132
Número: 8
Editorial: Lippincott Williams and Wilkins
Fecha de publicación: 2015
Página de inicio: 624
Página final: 632
Idioma: English
DOI:

10.1161/CIRCULATIONAHA.114.014807

Notas: ISI, SCOPUS